Motor Unit Number Index (MUNIX): A Biomarker for Evaluation of Lower Motor Neuron Involvement in Amyotrophic Lateral Sclerosis

被引：0
作者：
Abramova A.A. [1 ]
Broutian A.G. [1 ]
Zakharova M.N. [1 ]
机构：
[1] Research Center of Neurology, Moscow
来源：
Human Physiology | 2020年 / 46卷 / 8期
关键词：
amyotrophic lateral sclerosis; biomarkers; electromyography; motor neuron disease; motor unit number estimation; motor unit number index;
D O I：
10.1134/S0362119720080010
中图分类号：
学科分类号：
摘要：
Abstract: Although multiple clinical trials of various therapeutic interventions in amyotrophic lateral sclerosis (ALS) have been conducted so far, most of them lack comprehensive study design due to the absence of progression biomarkers that could provide adequate understanding of the rate and pattern of disease progression. Motor unit number estimation (MUNE) methods, motor unit number index (MUNIX) in particular, could be a promising tool for evaluating progression in ALS. This paper provides an extensive review of the main aspects of current MUNIX methodology and its emerging modifications, correlations with clinical and electrodiagnostic measures, reproducibility issues, utility in motor neuron disease diagnostics, and assessment of disease progression in clinical trials. © 2020, Pleiades Publishing, Inc.
引用
收藏
页码：900 / 911
页数：11
相关论文
共 70 条
[1]  
Brown R.H., Al-Chalabi A., Amyotrophic lateral sclerosis, N. Engl. J. Med, 377, (2017)
[2]  
Brooks B.R., El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotrophic Lateral Scler. Other Mot. Neuron Disord, 1, (2000)
[3]  
Wobst H.J., The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future, Med. Res. Rev, 40, (2020)
[4]  
de Carvalho M., Costa J., Swash M., Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements, Amyotrophic Lateral Scler. Other Mot. Neuron Disord, 6, (2005)
[5]  
de Carvalho M., Motor unit number estimation (MUNE): where are we now?, Clin. Neurophysiol, 129, (2018)
[6]  
de Carvalho M., Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials, Amyotrophic Lateral Scler. Other Mot. Neuron Disord, 6, (2005)
[7]  
Henderson R.D., McCombe P.A., Assessment of motor units in neuromuscular disease, Neurotherapeutics, 14, (2017)
[8]  
McComas A., Electrophysiological estimation of the number of motor units within a human muscle, J. Neurol., Neurosurg. Psychiatry, 34, (1971)
[9]  
Geijo-Barrientos E., Intramuscular injection of bone marrow stem cells in amyotrophic lateral sclerosis patients: a randomized clinical trial, Front. Neurosci, 14, (2020)
[10]  
Lingor P., ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis, Front. Neurol, 10, (2019)
1234567